VeriMomБезопасен ли hypericum perforatum leaf extract при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
Pregnancy-safe products containing hypericum perforatum leaf extract
Related ingredients
Frequently asked questions
- Безопасен ли hypericum perforatum leaf extract при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
- Безопасен ли hypericum perforatum leaf extract при грудном вскармливании?
- No regulatory harmonised reproductive/breastfeeding classification. While oral St. John's wort is known for systemic drug interactions and there are reports of transfer with systemic use, topical cosmetic use of the leaf extract is not established to cause significant transfer into breastmilk; therefore hazard and mechanism are scored 0 and exposure is low but measurable (e=1). Sources: PubMed (systemic use literature), CosIng, ECHA (no harmonised CLP).
- Безопасен ли hypericum perforatum leaf extract для кожи малыша?
- No evidence of a reproductive or developmental hazard specific to infants from topical exposure to Hypericum perforatum leaf extract; mechanism of reproductive toxicity is not demonstrated. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight, dermal exposure is increased relative to adults, so exposure is increased to moderate (adult e=1 → infant e=2). Note: phototoxic constituents (e.g., hypericin) may increase skin reaction risk but that is separate from reproductive classification. Sources: CosIng, PubMed (phototoxicity literature), ECHA (no harmonised CLP).
- Как VeriMom оценивает hypericum perforatum leaf extract?
- VeriMom оценивает hypericum perforatum leaf extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы hypericum perforatum leaf extract при беременности?
- См. наш список безопасных альтернатив hypericum perforatum leaf extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.